Theauthors treated 16 outpatients and I inpatient i’ho had diagnoses ofschizophrenia in exacerbation i’ith haloperidol as the sole neuroleptic agent and obtained ratings ofpsychopathology and serum levels of haloperidol. Improvement in schizophrenic symptoms measured by the BriefPsychiatric Rating Scale i’as significantly greater in patients who had mean haloperidol serum concentrations in the range of8-18 ng/ml than in patients whose mean haloperidol serum concentrationfell outside this range. H aloperidol is one of the most widely used antipsy-chotic drugs. High potency and a low ratio of un-wanted effects make haloperidol preferable to many drugs with lower potency and less specific antipsy-chotic action. Relatively few studies have atte...
Objective: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safet...
The aim of this study was to develop a pharmacokinetic-pharmacodynamic (PKPD) model that quantifies ...
Schizophrenic patients are heterogeneous with respect to voluntary eye movement performance, with so...
Twenty-nine hospitalized patients suffering acute exacerbations of schizophrenia were treated for 2 ...
Texto completo: acesso restrito. p.229–236Haloperidol, the most studied antipsychotic drug, is the o...
Most antipsychotic drugs share similar pharmacological properties in that they cause anti-dopaminerg...
International audienceOBJECTIVE: We report preliminary results from use of a radioreceptor assay (RR...
1.Haloperidol and reduced haloperidol plasma levels were measured in schizophrenic patients who re...
Objective: To determine the doses of haloperidol as a comparator drug in randomized controlled trial...
Objective: To determine the doses of haloperidol as a comparator drug in randomized controlled trial...
Haloperidol is widely considered a reference standard in antipsychotic therapy and is commonly used ...
none6noneGiegling I.; Drago A.; Schafer M.; Moller H.J.; Rujescu D.; Serretti A.Giegling I.; Drago A...
BACKGROUND: Previous studies had reported that serum brain derived neurotrophic factor (BDNF) levels...
A 6 week double-blind placebo-controlled trial of cyproheptadine augmentation of ongoing haloperidol...
Background: Many studies have indicated that immune cytokines may be involved in the pathophysiology...
Objective: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safet...
The aim of this study was to develop a pharmacokinetic-pharmacodynamic (PKPD) model that quantifies ...
Schizophrenic patients are heterogeneous with respect to voluntary eye movement performance, with so...
Twenty-nine hospitalized patients suffering acute exacerbations of schizophrenia were treated for 2 ...
Texto completo: acesso restrito. p.229–236Haloperidol, the most studied antipsychotic drug, is the o...
Most antipsychotic drugs share similar pharmacological properties in that they cause anti-dopaminerg...
International audienceOBJECTIVE: We report preliminary results from use of a radioreceptor assay (RR...
1.Haloperidol and reduced haloperidol plasma levels were measured in schizophrenic patients who re...
Objective: To determine the doses of haloperidol as a comparator drug in randomized controlled trial...
Objective: To determine the doses of haloperidol as a comparator drug in randomized controlled trial...
Haloperidol is widely considered a reference standard in antipsychotic therapy and is commonly used ...
none6noneGiegling I.; Drago A.; Schafer M.; Moller H.J.; Rujescu D.; Serretti A.Giegling I.; Drago A...
BACKGROUND: Previous studies had reported that serum brain derived neurotrophic factor (BDNF) levels...
A 6 week double-blind placebo-controlled trial of cyproheptadine augmentation of ongoing haloperidol...
Background: Many studies have indicated that immune cytokines may be involved in the pathophysiology...
Objective: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safet...
The aim of this study was to develop a pharmacokinetic-pharmacodynamic (PKPD) model that quantifies ...
Schizophrenic patients are heterogeneous with respect to voluntary eye movement performance, with so...